Prevalence of small cerebral bleeds in patients with a neurodegenerative dementia: a neuropathological study

Jacques De Reuck1, Vincent Deramecourt, Charlotte Cordonnier

  • 1Université Lille Nord de France, UDSL, F-59000 Lille, France. dereuck.j@gmail.com

Abstract

Insights

Post-mortem analysis reveals micro- and mini-bleeds (MnBs) are common in Alzheimer dementia (AD) brains, especially in the cortex. Dementia with Lewy bodies (DLB) also shows frequent MnBs, often linked to hypertension and AD pathology.

Area of Science:

  • Neuropathology
  • Neurodegenerative Diseases
  • Cerebrovascular Health

Background:

  • Small cerebral bleeds are common in Alzheimer dementia (AD) patients, but post-mortem histological data is limited.
  • This study investigates cerebrovascular lesions and "bleeding load" in neurodegenerative dementia post-mortem brains.

Purpose of the Study:

  • To determine the prevalence of cerebrovascular lesions, including micro- and mini-bleeds (MnBs), in post-mortem brains of patients with AD, dementia with Lewy bodies (DLB), and fronto-temporal dementia (FTD).
  • To quantify the "bleeding load" and compare lesion frequency across different dementia types and controls.

Main Methods:

  • Histological examination of 45 AD, 8 DLB, 12 FTD, and 10 control brains.
  • Evaluation of cerebral amyloid angiopathy (CAA), white matter changes (WMCs), micro-infarcts, and MnBs.
  • Semi-quantitative assessment of MnBs on coronal and horizontal brain sections.

Main Results:

  • Arterial hypertension was a key risk factor in AD and DLB patients.
  • Micro- and mini-bleeds (MnBs) were significantly more frequent in AD brains (P<0.001) and common in the cerebral cortex of both AD and DLB brains.
  • Cerebral amyloid angiopathy (CAA) and white matter changes (WMCs) were more prevalent in AD brains.

Conclusions:

  • This neuropathological study confirms frequent MnBs and WMCs in AD brains.
  • The high incidence of cortical MnBs in DLB brains is likely due to arterial hypertension and co-existing AD and CAA pathologies.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...